Julia B. Zella, Ph.D.
Affiliations: | University of Wisconsin, Madison, Madison, WI |
Area:
vitamins A and DGoogle:
"Julia Zella"Mean distance: 11.45
Parents
Sign in to add mentor| Hector Floyd DeLuca | grad student | 2002 | UW Madison | |
| (A therapeutic application of 1,25-dihydroxyvitamin D3 in the non-obese diabetic mouse model of type 1 diabetes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Plum LA, Zella J, Clagett-Dame M, et al. (2019) A New 1,25 Dihydroxy Vitamin D Analog with Strong Bone Anabolic Activity in OVX Rats with Little or No Bone Resorptive Activity. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research |
| Pandey R, Zella JB, Zhu JG, et al. (2017) Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D3) in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism on Hemodialysis. Drugs in R&D |
| Thadhani R, Zella JB, Knutson DC, et al. (2016) 2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial. American Journal of Nephrology. 45: 40-48 |
| Pandey R, Zella J, Clagett-Dame M, et al. (2016) Use of 2MD, a Novel Oral Calcitriol Analog, in Hemodialysis Patients with Secondary Hyperparathyroidism. American Journal of Nephrology. 43: 213-220 |
| Zella JB, Plum LA, Plowchalk DR, et al. (2014) Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women American Journal of Nephrology. 39: 476-483 |
| Ni Z, Qian J, Yang X, et al. (2014) Contents Vol. 39, 2014 American Journal of Nephrology. 39 |
| Plum LA, Zella JB. (2012) Vitamin D compounds and diabetic nephropathy. Archives of Biochemistry and Biophysics. 523: 87-94 |
| Williams KB, Barycka K, Zella JB, et al. (2009) Diaminobutane (DAB) dendrimers are potent binders of oral phosphate Journal of Bone and Mineral Research. 24: 97-101 |
| Plum LA, Fitzpatrick LA, Ma X, et al. (2006) 2MD, a new anabolic agent for osteoporosis treatment Osteoporosis International. 17: 704-715 |
| Zella JB, McCary LC, DeLuca HF. (2003) Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Archives of Biochemistry and Biophysics. 417: 77-80 |